G

GE Healthcare

Imaging, monitoring, and healthcare IT solutions

Senior Product Manager Next Generation MRI Solutions

Full-TimeUpdated on 10/23/2026
No salary listed
Senior, Expert
Master's, PhD
Waukesha, WI, USA
In PersonRelocation assistance is provided.
ProductProduct Management
No H1B Sponsorship

About the job

Requirements
  • A master's degree in Engineering, MRI Physics, Biomedical Engineering, Computer Science, Medical Imaging, or a related technical field is required.
  • At least 8 years of experience in Product Management, Product Definition, Systems Engineering, Research & Development, or Technology Development within medical imaging or medical devices is required.
  • Experience defining and commercializing MRI, software, or artificial-intelligence-enabled healthcare products is required.
  • Experience developing product requirements, product roadmaps, business cases, market assessments, and commercialization plans is required.
  • A strong understanding of MRI technology, clinical imaging workflows, and healthcare market dynamics is required.
  • Demonstrated ability to lead complex cross-functional initiatives and build alignment across diverse stakeholders is required.
Responsibilities
  • Define the strategy and multi-generation roadmap for next-generation MRI solutions, artificial-intelligence-enabled capabilities, and workflow innovations.
  • Lead end-to-end product definition, including customer segments, intended use, user needs, clinical and operational workflows, product requirements, feature prioritization, and value propositions.
  • Translate customer feedback, clinical insights, competitive intelligence, and market trends into actionable product requirements.
  • Develop product requirement documents, use cases, workflow specifications, release content, and acceptance criteria with cross-functional teams.
  • Identify product capabilities and technology investments that create differentiation and customer value.
  • Evaluate trade-offs involving customer needs, clinical impact, technical feasibility, regulatory requirements, business priorities, investment needs, and timing.
  • Develop and maintain business plans for new MRI solutions, including market opportunity assessments, customer segmentation, competitive positioning, adoption assumptions, pricing considerations, investment needs, risks, and financial impact.
  • Build business cases and investment recommendations connecting product capabilities to customer value, market demand, and growth opportunities.
  • Partner with Marketing, Commercial, Regional, and Finance teams to develop revenue forecasts, market share objectives, customer adoption goals, and launch assumptions.
  • Identify opportunities to expand market reach, increase product adoption, strengthen competitive positioning, and support portfolio growth.
  • Monitor market performance and recommend adjustments to product strategy, roadmap priorities, positioning, pricing, and commercialization plans.
  • Engage customers, key opinion leaders, clinical researchers, technologists, radiologists, field teams, and regional stakeholders to understand clinical and operational needs.
  • Lead structured customer research and translate insights into prioritized user needs and product requirements.
  • Conduct market, customer, and competitive assessments to identify opportunities for differentiation and growth.
  • Validate product concepts, workflows, value propositions, and adoption assumptions with representative customers and stakeholders.
  • Develop understanding of clinical, operational, and economic value drivers across priority customer segments.
  • Develop and maintain the product roadmap, balancing near-term customer needs with long-term platform evolution.
  • Partner with Engineering, Research, Clinical, Applications, and Technology teams to define and mature capabilities for future product releases.
  • Ensure external collaborations and advanced technology development timelines align with product release plans and program milestones.
  • Provide product leadership throughout the new product introduction lifecycle, from concept and feasibility through development, verification, validation, launch, and post-launch evaluation.
  • Lead roadmap and product reviews, communicate priorities, and facilitate data-driven decision-making across stakeholders.
  • Partner with Regulatory and Clinical Affairs teams to define evidence plans, intended claims, and regulatory strategies supporting product value.
  • Collaborate with global and regional marketing teams to develop product positioning, messaging, launch strategies, and customer engagement plans.
  • Translate product capabilities into clinical, operational, and economic value propositions that support customer adoption and commercial success.
  • Support customer advisory boards, clinical collaborations, industry events, internal training programs, launch activities, and sales initiatives.
  • Partner with Marketing Communications to develop launch collateral, sales enablement tools, competitive materials, and new product introduction communications.
  • Work with Commercial and Regional teams to monitor launch readiness, customer adoption, revenue performance, and pipeline development.
  • Track revenue contribution, market share, adoption, customer conversion, and portfolio performance, and recommend improvements.
  • Foster alignment across Product Management, Engineering, Clinical, Applications, Research, Regulatory, Quality, Marketing, Finance, and Commercial teams.
  • Build partnerships and influence stakeholders across a global matrix organization to align resources and decisions with customer and business priorities.
  • Communicate product strategy, business rationale, risks, dependencies, and progress to senior leaders and cross-functional teams.
  • Establish operating mechanisms and metrics to monitor roadmap execution, market readiness, and business outcomes.
  • Champion integrity, quality standards, regulatory requirements, environmental health and safety expectations, and continuous improvement.
Desired Qualifications
  • A PhD in MRI Physics, Biomedical Engineering, Electrical Engineering, Computer Science, or a related field is preferred.
  • Deep expertise in MRI product management, product definition, roadmap development, new product introduction execution, and lifecycle management is preferred.
  • Experience with artificial intelligence, machine learning, image reconstruction, workflow optimization, and advanced imaging technologies is preferred.
  • Experience developing business plans, financial models, pricing strategies, and revenue forecasts for medical imaging products is preferred.
  • A strong understanding of MRI clinical applications, image quality, scanner workflow design, and advanced imaging techniques is preferred.
  • Experience supporting regulatory submissions, clinical evidence generation, claims development, and commercialization of medical imaging products is preferred.
  • Experience collaborating globally with customers, academic institutions, research partners, and external technology organizations is preferred.
  • Strategic thinking, analytical, communication, influencing, and presentation skills are preferred.
  • A customer-focused and collaborative approach, with the ability to drive initiatives from concept through execution, is preferred.

About the company

GE Healthcare Systems provides medical technologies and digital infrastructure to improve diagnosis, treatment, and monitoring of patients. Its products include imaging systems, mobile diagnostic devices, patient monitoring tools, and healthcare IT software that work together as hardware, software, and services to support hospitals, clinics, and researchers. The company differentiates itself with a large, integrated ecosystem, strong focus on AI analytics, and a global service network backed by substantial R&D investment. Its goal is to improve patient outcomes and the efficiency of healthcare delivery by enabling accurate diagnoses, effective treatments, and scaled operations.

Company Size

1-10

Company Stage

IPO

Headquarters

Chicago, Illinois

Founded

1892

Get referred to GE Healthcare

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Q2 2026 orders rose 11% and backlog reached a record $23.9 billion.
  • CareIntellect for Operations launched September 2026 with Duke Health and Queen's Health Systems.
  • CE mark and FDA progress for Photonova Spectra expand 2026-2027 commercial momentum.

What critics are saying

  • FDA logged multiple 2026 Class 2 recalls, including AW Server and telemetry systems.
  • Patient Care Solutions remained weak in Q2 2026; management is reviewing a sale.
  • SOFIE closes only after 2027 regulatory approvals; PET supply integration can slip badly.

What makes GE Healthcare unique

  • GE HealthCare combines imaging hardware, radiopharmaceuticals, and workflow software across hospitals.
  • Photonova Spectra and Vivid 2026 show premium innovation plus AI-enabled clinical automation.
  • SOFIE's 21 cyclotrons extend GE HealthCare into radiotracer manufacturing, not just scanners.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Health Insurance
  • Dental Insurance
  • Vision Insurance
  • Life Insurance
  • Disability Insurance
  • 401(k) Retirement Plan
  • 401(k) Company Match
  • Tuition Reimbursement
  • Relocation Assistance

Company News

Yahoo Finance
Oct 23rd, 2026
Cash-rich stocks: Clean Harbors worth watching, UPS and GE HealthCare best avoided

StockStory has named one cash-generating stock worth a closer look and two it would avoid, arguing that strong cash flow does not always mean strong returns. Clean Harbors (NYSE:CLH) is the pick. Its revenue grew 13.5% a year over five years, and earnings per share rose 21.6% a year, helped by share buybacks. Its free cash flow margin is 8.8%, up 5.9 percentage points over five years. The shares trade at $320.91, or 30.7x forward earnings. StockStory would steer clear of United Parcel Service (NYSE:UPS) and GE HealthCare (NASDAQ:GEHC). UPS sales were flat over five years while earnings per share fell 8.4% a year. GE HealthCare faces projected sales growth of 4.4% and a 1.7-point drop in adjusted operating margin.

Associated Press
Oct 20th, 2026
GE HealthCare launches five-institution global trial of StarGuide GX theranostics SPECT/CT system

GE HealthCare has launched a clinical evaluation program for StarGuide GX, its next-generation digital 4D SPECT/CT system. Five institutions across three continents will take part. They are Hadassah Medical Center and Rambam Health Care Campus in Israel, Mayo Clinic in the US, Oncopole Claudius Regaud in France, and Peking University First Hospital in China. Each will assess image quality, quantitative performance, dynamic imaging, and workflow, and give feedback to guide the system's development. StarGuide GX uses dual-sided cadmium zinc telluride detectors and a dual-collimator design meant to remove manual collimator changes. It also uses NVIDIA RTX accelerated computing for image reconstruction. The system received CE Mark in November 2025 and is on sale in select EU states. Its US Food and Drug Administration 510(k) clearance is pending.

Yahoo Finance
Oct 19th, 2026
GE HealthCare launches LOGIQ Focus ultrasound with AI tools, 26% faster scans

GE HealthCare has launched LOGIQ Focus, a new general imaging ultrasound system in its LOGIQ family. The company announced the product in Chicago on October 19, 2026. The system runs on cSound Architecture and pairs high-definition imaging with AI-enabled tools. One of them, Auto Preset Assistant, detects the anatomy being scanned and activates the matching preset, saving up to five clicks per exam. In a third-party study, 90% of participants rated its image quality as excellent. The system was 26% faster than the predicate system. LOGIQ Focus is 510(k) cleared and CE Marked. GE HealthCare expects it and several other new products to add 1% to 2% to revenue growth, following more than $5 billion in innovation investment since 2023.

Business Wire
Oct 5th, 2026
GE HealthCare to acquire SOFIE Biosciences for $945M to expand US radiopharmaceutical supply

GE HealthCare has agreed to acquire SOFIE Biosciences, a US-based contract manufacturer of PET radiopharmaceuticals, for $945 million in cash. The deal with seller Trilantic North America is expected to close in the first half of 2027, subject to regulatory approvals. SOFIE Biosciences operates 15 contract manufacturing sites with 21 cyclotrons across the US, plus a theranostics-focused development and manufacturing facility. The acquisition establishes GE HealthCare's presence in the time-critical "final mile" of US PET radiopharmaceutical supply. The PET radiopharmaceutical market is expanding rapidly with approximately 20 PET radiotracers and over 30 radiotherapeutics currently under development. SOFIE Biosciences' portfolio includes a Phase III FAPI asset for which GE HealthCare already holds non-US rights. GE HealthCare estimates the transaction will be accretive to revenue growth, earnings margin, and earnings per share in the first full year of ownership.

PR Newswire
Sep 30th, 2026
AsiaMedic first in ASEAN to deploy GE HealthCare's MR31 deep learning MRI platform

AsiaMedic has become the first site in ASEAN to implement MR31, GE HealthCare's latest generation MRI platform featuring deep learning technology. The Singapore-based imaging centre is among the earliest adopters in Asia Pacific. MR31 incorporates deep learning technologies that reduce scan times and enable detailed examinations across neurological, musculoskeletal and nerve imaging. Sonic DL for 3D delivers up to 12 times scan acceleration, reducing examination times across brain, spine, orthopaedic and body scans. The platform also supports high-quality prostate MRI imaging. AIR Recon DL Phase Correction provides improved visualisation of clinically significant lesions, whilst high-resolution T2-weighted imaging aids lesion localisation for prostate fusion biopsy planning. Shorter scan times mean reduced patient time in scanners and may help decrease repeat examinations caused by movement.